BRAoVO™ Plus Cancer Gene Panel | Genomic Diagnostics

Test description

This panel is important for breast cancer patients with a family history that includes ovarian cancer and is also useful for families where there is a mixed cancer picture of breast +/- ovarian +/- colorectal cancer.

Test information

Test name

BRAoVO™ Plus Cancer Gene Panel

‍

Clinical indication

Used to:

1. Determine risk for patients with a personal and/or family history suggestive of Hereditary Breast and Ovarian Cancer Syndrome.

Gene(s)

ATM, BARD1, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53, MLH1, MSH2, MSH6, PMS2, EPCAM

Method

Massively Parallel Sequencing

Turn around time

4 weeks

Medicare eligibility

73296 – conditions apply

‍73354 – conditions apply

‍73295 – conditions apply

‍73304 – conditions apply

Price

$575 if not Medicare eligible

Test request form

Cancer genetics test request form preferred. Standard pathology request form accepted.

Sample type

Blood x 2

Collection type

6mL EDTA tube

Special instructions

2 x Bloods taken at 10 minute intervals. Pre test genetic counselling required. Patient to sign consent form prior to testing.